Therefore, this work aims to develop and validate two easy-to-use ELISAs to quantify a-PD-1 and a-PD-L1 plasma concentrations collected from tumor-bearing mice and determine the PK profiles and main parameters of these agents. This evidence concerns the gene CD274 and neoplasm.